This led Qiu et al. to assess the gut microbial translocation using biomarkers EndoCAb-IgM and LPS-sCD14 and also assess the dysbiosis-associated chronic system inflammation in MG subjects using other biomarkers involving IL-6 and tumor necrosis factor-alpha (TNF-α). The gene discussed is CD40LG; the disease is myasthenia gravis.